The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
Clinical trial NCT07285850 · RECRUITING
Trial details
- NCT number
- NCT07285850
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2026-08-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.